300 results on '"Zolty, R."'
Search Results
52. (1113) - Left Ventricular Assist Device Improves Type II Pulmonary Hypertension with High Pulmonary Vascular Resistance
53. (1033) - Psychosocial Factors and Outcomes with Left Ventricular Assist Device Therapy
54. (1013) - Depression in Patients Undergoing Left Ventricular Assist Device Implantation
55. Heart Failure with Preserved Ejection Fraction Induced Reactive Pulmonary Hypertension Lacks Nitric Oxide Vasoreactivity Similar to Pulmonary Arterial Hypertension
56. Mineralocorticoid Receptor Antagonists Enhance Cardiac Function during Continuous Flow Left Ventricular Assist Device Support
57. Left Ventricular Internal Diastolic Diameter as a Predictor of Outcomes in Ischemic Cardiomyopathy
58. Differentiating Heart Failure with Preserved Ejection Fraction Induced Pulmonary Hypertension from Pulmonary Hypertension Using Demographic Data and Common Blood Measurements
59. Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin- Receptor Blockers (ARBs) during CF-LVAD Support Are Associated with Sustained Improvement in Renal Function
60. Intracranial Hemorrhage Is Associated with a Higher Doppler Blood Pressure during Continuous Flow Left Ventricular Assist Device Support
61. (1087) - Oxydative Stress in Heart Failure Patients after Implantation of Continuous Flow Left Ventricular Assist Devices
62. (1043) - Myocarditis Treated with VA-ECMO: A Single Centers Experience
63. (822) - Cardiac Allograft Sinus Tachycardia Is Associated with Impaired Exercise Tolerance
64. (778) - CMV Reactivation Using Valganciclovir vs Valacyclovir in Moderate Risk Heart Transplant Recipients
65. (748) - Heart Failure Patients’ Quality of Life and Perception of Palliative Care
66. (526) - Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients
67. 819 Does a Low Ejection Fraction Predict Mortality? Insights From the ASCEND-HF Trial
68. 833 Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
69. 838 Differences in Mortality and Morbidity in Pulmonary Hypertension Secondary to Systolic vs. Diastolic Heart Failure
70. 430 The Role of Cardiac Biomarkers in Takotsubo Cardiomyopathy
71. 621 Endothelin-1 Levels in Pulmonary Hypertension: A Comparison between Pulmonary Arterial Hypertension and Diastolic Heart Failure-Induced Pulmonary Hypertension
72. 616 Bradykinin Targeted Therapy Decreases Mortality in Pulmonary Hypertension
73. 499 Improved Survival with Statin Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
74. 21 Relaxin Levels Elevated in Patients with Pulmonary Arterial Hypertension
75. 310 Hypoalbuminemia Is a Predictor of Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
76. 309 Mortality in Pulmonary Hypertension Stratified by Sedimentation Rate
77. 678 Dose-Dependent Improvement in Survival with ACE Inhibitor Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
78. 504 Improved Survival with Pioglitazone in Patients with Diabetes Mellitus, Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction: A Comparative Effectiveness Analysis
79. 215 Higher Doses of Spirinolactone Are Associated with Lower Survival in Patients with Congestive Heart Failure
80. 503 Anti-Inflammatory Drugs Improve Mortality in Pulmonary Hypertension
81. 313 Effect of Nesiritide on Renal Function in Patients with Decompensated Diastolic Heart Failure Secondary to Pulmonary Hypertension
82. 214 Improved Survival with Sustained Release Metoprolol When Compared to Carvedilol in Patients with Ischemic Heart Failure: A Comparative Effectiveness Analysis
83. 308 Role of Inflammation in Patients with Both Pulmonary Hypertension and Atrial Fibrillation
84. 47: Mortality and Readmission Rates with Dobutamine and Milrinone in Pulmonary Hypertension and Right Ventricular Failure
85. 435: Pulmonary Artery Hypertension: Endothelial Dysfunction and Statin Treatment
86. 49: Pulmonary Artery Hypertension: Heart Failure and ACE Inhibition
87. 575: Hyponatremia on Admission Predicts Longer Length of Stay in Patients with Pulmonary Hypertension and Right Ventricular Failure
88. 436: Mortality and Readmission Rates in Hyponatremic Patients with Pulmonary Hypertension and Right Ventricular Failure
89. 288: Aldosterone Antagonism in Pulmonary Hypertension and Right Heart Failure
90. 59: Nesiritide Worsens Renal Insufficiency in Patients with Right Ventricular Failure Due to Pulmonary Hypertension
91. Combination of Axial Flow Circulatory Support and Aggressive Neurohormonal Blockade for Recovery of Cardiac Function in Advanced Heart Failure
92. 573: Normalization of Fixed Pulmonary Hypertension in Severe Heart Failure Patients with Placement of Left Ventricular Assist Device
93. 589: New York Heart Association Functional Class Correlates Poorly with Peak Oxygen Consumption during Cardiopulmonary Exercise Tolerance Testing: Implications for Orthotopic Heart Transplantation
94. 332: Molecular Remodeling on Beta-Blocker Therapy in the Failing Human Heart
95. Serial Gene Expression Profiling in the Intact Human Heart
96. Effect of Thyroid Hormone on Myocardial Gene Expression, Hemodynamics and Exercise in Heart Failure
97. 250 EFFECT OF THYROID HORMONE ON MYOCARDIAL GENE EXPRESSION, HEMODYNAMICS AND EXERCISE IN HEART FAILURE
98. Peak oxygen consumption and outcome in heart failure patients chronically treated with β-blockers
99. (547) - Mineralocorticoid Receptor Antagonists Enhance Cardiac Function during Continuous Flow Left Ventricular Assist Device Support
100. (751) - Left Ventricular Internal Diastolic Diameter as a Predictor of Outcomes in Ischemic Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.